Biointegrated and wirelessly powered implantable brain devices: a review by Das, Rupam et al.
 
 
 
 
 
Das, R., Moradi, F. and Heidari, H. (2020) Biointegrated and wirelessly 
powered implantable brain devices: a review. IEEE Transactions on 
Biomedical Circuits and Systems, (doi:10.1109/TBCAS.2020.2966920). 
 
This is the author’s final accepted version. 
 
There may be differences between this version and the published version. 
You are advised to consult the publisher’s version if you wish to cite from 
it. 
 
http://eprints.gla.ac.uk/194197/    
                    
 
 
 
 
 
 
Deposited on: 14 January 2020 
 
 
 
 
 
 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk  
 
 1 
  
Abstract—Implantable neural interfacing devices have added 
significantly to neural engineering by introducing the low-
frequency oscillations of small populations of neurons known as 
local field potential as well as high-frequency action potentials of 
individual neurons. Regardless of the astounding progression as of 
late, conventional neural modulating system is still incapable to 
achieve the desired chronic in vivo implantation. The real 
constraint emerges from mechanical and physical diﬀerences 
between implants and brain tissue that initiates an inflammatory 
reaction and glial scar formation that reduces the recording and 
stimulation quality. Furthermore, traditional strategies consisting 
of rigid and tethered neural devices cause substantial tissue 
damage and impede the natural behaviour of an animal, thus 
hindering chronic in vivo measurements. Therefore, enabling fully 
implantable neural devices requires biocompatibility, wireless 
power/data capability, biointegration using thin and flexible 
electronics, and chronic recording properties. This paper reviews 
biocompatibility and design approaches for developing 
biointegrated and wirelessly powered implantable neural devices 
in animals aimed at long-term neural interfacing and outlines 
current challenges toward developing the next generation of 
implantable neural devices. 
 
Index Terms— Biocompatibility, Biointegration, Implantable 
neural device, Mechanical flexibility, Wireless power transfer. 
 
I. INTRODUCTION 
dvances in neural engineering and related experimental 
methods improved our understanding of the brain. As for 
an example, progress in fMRI (functional magnetic 
resonance imaging) technologies expanded our insight of 
neuronal circuits and help us to understand how specific brain 
activity linked to different neural circuits [1]. However, size and 
portability limit the use of such neuroimaging tools to explore 
brain activity during daily living [2]. Furthermore, another 
crucial constraint of fMRI in brain research is the low 
spatiotemporal resolution. In contrary, portable surface 
electroencephalography (EEG) permits the uninterrupted 
monitoring and evaluation of brain activity macroscopically for 
a long period of time [3, 4].  However, same as with fMRI, the 
low spatiotemporal resolution of EEG sabotages the accuracy 
of measurement and is incompatible with neuroscience studies 
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on scenarios such as single-neuron resolution. Individual 
neurons constitute the morphological as well as operational 
units of the brain and their spatiotemporal recordings are key to 
properly understand the brain function.	  Nowadays, to record 
extracellular activities, including action potentials and local 
field potentials (LFPs), implantable neural devices are  most 
commonly used [5, 6]. 
These invasive and implantable neural interfacing devices 
are widely applied in different clinical scenarios for example,  
peripheral, and spinal nerve interfaces for monitoring epilepsy, 
cochlear and retinal implants, and as deep brain stimulators [7-
11]. Like most of the implantable devices, the exceedingly 
dynamic and corrosive condition of the biological tissue is 
antagonistic to implants. The vulnerability originates due to 
mechanical and physical mismatch linking the implants and 
brain tissues which causes scar formation and introduces 
neuroinflammatory response, thus, gradually degrades the 
recorded neural signal [12-14]. As a result, implantable neural 
devices are required to be bioinert, physically soft and small 
enough to complement those of brain tissues. The goal is then 
developing neuron-like, multifunctional neural engineering 
platforms or neuroprostheses interfaces that enforce 
significantly low constraints on the normal environments of the 
brain and incites negligible inflammatory responses.  
Implantable neural devices based on tethered and rigid 
devices initiate considerable tissue damage and disturbance 
with the normal behaviour of animals, thereby hampering 
chronic in vivo operations [15-18]. The mechanical mismatch 
and micro-motion introduced by the interconnection that links 
the neural implant placed near the brain and skull-mounted 
connector (i.e. tether), can be minimized by using a wireless 
power system. The most commonly used wireless power 
technologies used are electromagnetic, photovoltaic, and 
ultrasound [15, 18]. The ultrasound-based power transfer 
method uses ultrasound to vibrate an energy harvester based on 
implantable piezoelectric. On the other hand, photovoltaic 
wireless power harvesting is based on the conversion of light 
into electricity by using photovoltaic cells. Although 
innovative, these wireless solutions are limited due to the 
complex circuitry and low power transfer distance. As a result, 
the electromagnetic based wireless power transfer, which 
working principle is the electromagnetic induction, still the 
R. Das and H. Heidari are with Microelectronics Lab (meLAB), School of 
Engineering, University of Glasgow, Glasgow, UK (e-mail:  
rupam.das@glasgow.ac.uk, hadi.heidari@glasgow.ac.uk)  
F. Moradi is with the Integrated Circuits and Electronics Lab (ICELab), 
Electrical Engineering Department, Aarhus University, Denmark (e-mail: 
moradi@eng.au.dk).  
Biointegrated and Wirelessly Powered 
Implantable Brain Devices: A Review 
Rupam Das, Member, IEEE, Farshad Moradi, Senior Member, IEEE and Hadi Heidari, Senior 
Member, IEEE 
A 
 2 
most popular choice to realize the fully implantable, wirelessly 
powered, and miniaturized neural devices for chronic 
implantation [15, 16, 18]. 
This paper studies novel design approaches for developing 
soft, flexible and wireless interfaces of implantable neural 
devices by manifesting physical and mechanical consistency 
with brain tissues. The review starts by considering different 
neural interfaces, incorporating key parameters to consider for 
implantable neural probes. Following sections highlights the 
challenges and progress in implantable probe biointegration 
using circuit analysis of the probe/tissue interface. In section 
III, most of the common wireless power modalities for 
implantable neural interface have been addressed including 
electromagnetic, ultrasound, and solar. Finally, there is a 
conclusion section, followed by the discussion on the state of 
the implantable neural interface suggesting scopes for future 
studies. 
II. NEURAL DEVICE INTERFACES 
Implantable neural probe (or electrode/device) defines as the 
interface between brain-machine interface (BMI) system and 
neurons—the electroactive cells of the nervous system. 
Basically, implantable neural devices were evolved as a 
fundamental neuroscience tool to enhance the understanding of 
physiological processes [19-22], and in BMI neural interfaces 
occupy exceptional ability to substitute for function of the 
various neurological disorders such as paralysis, epilepsy,  
other forms of motor dysfunction, or limb loss. The motivation 
behind developing neural devices is to provide adequate neural 
stimulation and/or to record the high quality neural signal from 
a few individual neurons, named action potentials [14]. 
  Brain signals may be categorized into EEG [23], 
electrocorticogram (ECoG) [24, 25], LFPs [26], and action 
potential [27], based on the location of the recorded signal. A 
correlation between the position and quality of the acquired 
 
Fig.  1. Examples of neural recording systems. (a) EEG probes are placed non-invasively on the brain scalp to record the neuronal activity. 
ECoG electrodes enable recording of neural activity on the cortical surface and implanted either inside (subdural) or outside (epidural) the dura 
mater. Implantable neural or cellular electrodes facilitates recording/stimulation from small numbers of neurons or individual neurons by 
penetrating the cortex and. (b) Fundamental principles and anatomical limitations of neural recording methods. Illustrate the trade-off and 
indicates an interrelation between the amount of temporal dynamics of neural technology and the spatiotemporal resolution that can be attained. 
(c)  Demonstrate the current research trend on neural interfaces. The data were collected from the Web of Science by searching keywords such 
as EEG, ECoG, and implantable neural probe. To show the relative comparison of the research rate from 1995 to 2018 among these technologies, 
the number of publications is normalized for each case. 
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signal among different neural technologies is displayed in 
Fig. 1(a). EEG (scalp recordings) is the most basic, non-
invasive technique to record brain activity, which has found 
application in the treatment of seizure or epilepsy. EEG also 
helps to monitor sleep, enables a better understanding of 
language perception and   psychological function of the brain 
[28-31]. However, due to several interfering LFPs, EEG is 
unable to offer nearby data concerning a speciﬁc brain region, 
and suffers from low transfer rates e.g. 5-25 bit/s [32, 33]. 
Furthermore, brain tissues are lossy and packed densely, and 
other brain layers such as skin and cranium function as 
obstacles that attenuate recorded  EEG signal to the surface 
electrode, thereby limiting the spatiotemporal resolution [34]. 
In contrast, current researches have evaluated the application of 
invasive BMI such as ECoG (epidural/subdural recordings). As 
compared to the EEG, ECoG reduces the noise interference and 
allows to record higher frequency neural signal with higher 
accuracy. This is due to the fact that the ECoG electrodes are 
implanted within the cortex, thus accommodating lower tissue 
interference between the neurons and the electrodes [35]. Still, 
however, ECoG just records neural signals from superﬁcial 
locales of the brain and unable to collect activity from 
individual neurons. Gathering signals from individual neurons 
and accuracy in spatiotemporal resolution over a particular 
neuron population is fundamental to facilitate a more profound 
understanding of the human sensory and cognitive system. 
Consequently, a more invasive method using implantable 
neural probes collect the LFPs signal from the deep brain 
region. The recording of LFPs signifies local neural activities 
which are obtained from specific neuronal densities and 
comprises action potentials as well as additional membrane 
potential ﬂuctuations, and provides noteworthy details about 
the measured brain area [36].  
Fundamentally, the idea of neural recording relies upon the 
application that we are focusing on. For an identical activity of 
the brain, the recorded signal is varied depending on the 
interfacing technique and recorded signal location. According 
to Fig. 1(b), EEG or fMRI help us to examine neural activity 
from the identical subject for a longer period with a low 
resolution, whereas an implantable neural probe can achieve 
neuronal scale resolutions with a short temporal span. From the 
historical perspective, the field of neural interfaces has shown 
an upward trend as evidenced in Fig. 1(c). This study is based 
on the number of publications (normalized) in the field of 
neural interfaces since the early 1990s. Among these, the 
current research trend indicates a significant development 
towards the implantable neural probe compared to the EEG and 
ECoG.  Ongoing investigations proposed single-neuron activity 
enables us to guide and better comprehend the wiring of the 
cerebrum and its connection to discernment, movement, and 
memory. Nowadays, implantable neural device utilized for 
confining epileptogenic regions and treating Parkinson's 
disease. As compared to EEG and ECoG, the implantable 
neural device is considered to generate the most valuable 
control signals for neural interfacing [35, 36]. These findings 
crave more breakthroughs in implantable device technologies 
to have more higher resolution, spatiotemporal span, and 
multiplexed functionality for neural recordings and 
stimulations. 
Recent progress in the field of materials science, stimulation 
types, system engineering, and mechanical design can facilitate 
long term in vivo recordings in freely moving animals by using 
implantable neural probes [5, 16]. Some key system parameters 
for designing implantable neural probes appear in Fig. 2. In all 
scenarios, a critical objective is to design a fully implantable, 
miniaturize, flexible, biointegrated, and wireless platforms [15, 
17, 18, 37-40]. Use of biocompatible material plays an 
important role both chemically and mechanically, and 
prerequisite to permit a durable, least invasive operation of the 
brain [41]. Along with the critical importance of the 
biocompatibility, mechanical flexibility as well as conformality 
to the desired tissues forms the foundation of a long-term 
biointegration [42]. Furthermore, wireless power transfer 
(WPT) to the neural implant ensures tether-free, highly mobile 
social connections or recordings in naturalistic situations for the 
tested animals [15, 17, 18]. In summary, reducing the size and 
weight is an inevitable engineering prospect [5]. 
III. RECENT TREND IN PROBE/TISSUE BIOINTEGRATION 
A. Equivalent circuit analysis of the probe/tissue interface:   
Neural recordings using implanted devices can detect a 
change in the extracellular field because of ion fluxes in the 
nearby condition, which permits recording of the small 
population activity as LFPs (<~350 Hz), and, in certain 
situations, the spiking action or action potentials of single-
neuron (~kHz). The impedance is defined as the resistance to 
the current that flows between the implanted probe and 
interface of the tissue. The impedance estimates the capacity to 
record the pathological and physiological neural sign or for 
neural stimulation. By making use of the equivalent circuit 
model illustrated in Fig. 3a, the probe/tissue effective 
 
Fig.  2. Schematic illustration of the key parameters in neuroscience 
research for implantable device. Examples of emerging tools include 
biointegration, biocompatibility, device miniaturization, wireless 
power and data transmission, stimulation types, mechanical flexibility, 
and electro-chemical durability. 
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impedance can often be modelled, understood, and optimized. 
Here, Ve is the signalling in the neuron and accepted as a low-
impedance voltage source. Rspread (or, Rmedia) indicates the 
impedance of the extracellular space and is dictated by the 
implanted device geometry. Besides, Re is the leakage 
resistance of the electrode and Ce characterizes the capacitance 
of the probe/tissue interface. Finally, Rs defines the resistance 
that exists in case of higher-level hardware, for example 
amplifiers. The magnitude of Rs can be negligible or significant 
depending on the interconnection used to record/transmit 
signals [43, 44]. In general, a lower impedance probe/tissue 
interface is desired and permits us to “see” the neural signal 
(Ve) more promptly. Like recording, implantable neural device 
stimulation is strengthened with a low probe/tissue interface 
resistance as well and results in a significant charge injection. 
Hence, having a low impedance interface is crucial in µm-scale 
electrodes for neural recording/stimulation. As both recording 
and stimulation circuits are identical to Fig. 3a, a ms-scale 
biphasic current stimulation introduces a momentary voltage 
incorporating rapid step, because of Rspread, and initiates a 
capacitive charging due to Ce [45]. Consequently, a small value 
of Ce facilitates the significant potential drops at the neural 
interface. This may introduce electrolysis of water, degradation 
of electrode, as well as tissue damage.  
Recent advancement in the microelectronics manufacturing 
promoted the development of patterned, micromachined, and 
rigid probes [46]. Nowadays, the state-of-the-art devices like 
Michigan-style probes [47] and Utah arrays [48] are 
commercially available and has been utilized in neuroscience 
research. Furthermore, emerging Silicon-based implantable 
probe technologies such as Neuropixels for high-density neural 
recordings [49], multifunctional probe [50], as well as 3D probe 
for recording of coordinated brain activity from large 
population of neurons [51] have enriched us with new insights 
to study the brain. Regardless of numerous triumphs and 
creative revelations in neuroscience (from the disclosure of spot 
and framework cells to mapping and motor cortex stimulation), 
still implantable neural devices face numerous limitations that 
circumscribe their chronic implementation. Owing to the rigid 
nature of the implanted devices, it frequently prompts insulation 
failure and limits the recording/stimulating ability [52]. 
Accordingly, recording quality, stimulation limit, and life 
expectancy of an implantable neural device can be condensed 
down to its capacity to oppose or defeat increments in electrical 
impedance. Due to the surgical procedure of the implantable 
neural device, it presents both intense (acute) and constant 
(chronic) tissue damage, notwithstanding, there are more 
spotlights on the probe/tissue biointegration and lifetime 
instead of the impact on neurological function [35]. In the 
following subsections some of the critical aspects of the 
implant/tissue biointegration will be addressed in terms of 
electrical viewpoint along with the approaches to alleviate these 
issues. 
B. Interruption in probe/tissue circuit due to implantation 
failures   
Poor encapsulation, material defects, and/or potentially 
unintended mechanical stresses causes cracking and 
delamination of the device [53]. Encapsulation failure, which 
occurs in between a week or a month after implantation, may 
expose the metallic interconnects. Insulation damage introduces 
additional resistive and capacitive pathways for current to flow 
(Rd and Cd in Fig. 3b). This results in a false neural signal (or, 
noise) VNT from undesired cells [54, 55]. In addition, the 
amplitude of the neural recording is diminished due to the low 
impedance shunting pathways of the neighbourhood condition. 
Likewise, these equivalent shunt pathways may divert current 
and stimulate non-target cells, decreasing stimulation ability.   
Corrosion due to chemical deterioration of the material used in 
the electrode presents a twofold negative impact. First, it 
destroys the conductive properties of the metallic interconnects 
(thus, expanding Rs as well as diminishing Ce) and secondly, 
 
Fig.  3. (a) Probe/tissue interface equivalent circuit. For simplicity, recording is assumed where, neurons operate like a voltage source (Ve). 
Nonetheless, stimulation circuit can also be represented similarly. (b) Schematic of the encapsulation failure of the implantable neural device 
and corresponding equivalent circuit. (c) Graphical illustration of the foreign-body response to a stiff implant in the brain and associated 
equivalent circuit. 
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accommodating brain with harmful toxic ingredients, 
subsequently, expanding the immune response or causes cell 
death [35]. Careful materials choice and/or synthesis are vital 
in realizing a chemically stable and properly insulated 
implantable neural electrode.  
Though acute tissue damage because of the implanted neural 
probe in the brain could expeditiously recuperate, it is the long 
haul tissue response, and consequent inflammation at the 
implant site, that effectively adds to debasing the probe/tissue 
biointegration [56, 57]. The neuroinflammatory reaction within 
the central nervous system of the brain is defined as the reaction 
of the immune system and is made from a blend of cellular and 
biochemical reactions, which detaches foreign components (for 
example, an implanted probe) from the tissue. During the acute 
stage, the surface of the implanted device attracts and activates 
microglia (central nervous system immune cell), which releases 
pro-inflammatory factors. Shortly thereafter, a thick astrocyte 
wraps the implanted neural device and the response advances 
to a chronic stage, where a scar (astrogliosis) is formed, as 
visualized in Fig. 3c. This chronic reaction, which is 
responsible for distancing the neuron from the implantation site 
can be caused by several factors [58]. In accordance with 
electrical interfacing, astrogliosis and the distancing of neurons 
near the implanted sites are in charge of (i) the introduction of 
additional impedance (Zscar) and (ii) diminishing the amplitude 
of the neural recordings since living neurons are less and 
remotely away from the implant site (Fig. 3c). According to the 
both theory and experiments, the most extreme permissible 
separation between the probe and the cell membrane for a 
steady recording extends somewhere in the range of 50 and 100 
µm [58]. An overview of the different failures upon the 
implantation of a probe into the intracortical tissue is illustrated 
in Fig. 4. 
C. Recent advancement in probe/tissue biointegration 
Biocompatibility of the neural interface can be evaluated 
quantitatively based on the estimation of the neuron population 
as a function of the distance from the implant. Furthermore, the 
spread of the neuroinﬂammation [59] and causes of neural 
interfacing failure can be examined by either electrochemical 
impedance spectroscopy [60] or optical analysis [61]. To 
enhance the biointegration of the implantable neural probe, 
biocompatibility holds the key.  
Biological compatibility or biocompatibility depends on the 
material properties (e.g. chemical, mechanical and physical) of 
the implant. In general, biocompatibility is characterized as the 
capacity of a biomaterial to fulfil its ideal operation regarding a 
medicinal treatment, without inspiring any bothersome local or 
systematic eﬀects in the recipient, yet producing the most 
proper cell or tissue reaction in that speciﬁc circumstance, and 
enhancing the clinically applicable presentation of that 
treatment [62]. Thus, a few methodologies have been proposed 
to improve the biocompatibility, for instance, enhanced device 
encapsulations can beat the electrical impacts from scar 
formations, and a decrease in device corrosion can limit the 
initiated neuroinflammatory responses. However, mechanical 
discrepancy between probe/tissue interface affects the long-
term biocompatibility of the implanted neural device. 
Lack of mechanical uniformity between the brain and 
implanted device and micromotions are both associated with 
scar formation. A mechanically compliant device to the neural 
tissue is expected to enable the implanted device to pursue the 
movements of the brain.  Bending stiffness and Young’s 
modulus are the two physical quantities that are normally used 
to depict inflexibility or the protection from a twist or 
deformation. In identifying the amount of mechanical 
incompatibility, the bending stiffness of a specific implantable 
neural device is more critical than Young’s modulus [55, 63]. 
Fig. 5a represents the scope of Young's moduli of different 
neural devices and neural tissue. To add more, the compelling 
bending stiffness estimations of traditional and emergent neural 
devices [64-69] alongside that of a 20-100 μm thick slice of 
brain tissue [70], are plotted in Fig. 5b. Consequently, the 
mitigation of mechanical mismatch can be approached from 
two directions. Firstly, making polymer based flexible neural 
device as polymers such as such as Parylene C, polyimide, or 
SU-8 are softer than bulk Si and metals. Recently, S. Guan et 
al. introduced the Neurotassel probe based on polyimide 
comprising of numbers of flexible and high–aspect ratio 
microelectrode filaments, which can provide chronic recordings 
3-6 weeks after implantation [71]. However, polymer based 
neural devices are still significantly stiffer than tissue. Shifting 
to increasingly agreeable materials, for example, 
Polydimethylsiloxane (PDMS) or hydrogel coatings shuts this 
gap [35, 42], as in Fig. 5a. Implantable neural probes based on 
the elastomeric substrate (e.g. PDMS) can be stretchable and 
enable chronic multimodal neuromodulation applications [72]. 
The second method recommends stiff materials such as 
polymers, metals, and semiconductor can be utilized if the 
characteristics dimensions of the implanted probes are in 
subcellular scale (1 to 10 µm) to take into account mechanical 
consistency [35].  
Fig. 5c shows the some of the current research trends in 
designing the biointegrated implantable neural probe. Most of 
the recent neural devices based on ultra-small carbon [68, 73], 
polyimide [65] and elastomer-based ‘e-dura’ probes [72], as 
well as traditional microwire and Michigan-type silicon devices 
are still considerably stiffer than the brain tissue. Moreover, 
probe/tissue biointegration often requires stretch ability (a low-
modulus, elastic reaction to huge strain distortions) and this can 
 
Fig.  4. Failure modes of neural device include chemical reaction or 
corrosion, encapsulation failure, delamination or cracking of 
insulation. Failures related to biology include blood barrier breach, 
implant micromotion, interruption of glial networks, formation of glial 
cells and neuronal death, recreated from ref [55]. 
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be accomplished with characteristically resilient materials or 
through introducing deterministic, composite shapes utilizing 
serpentine structures, and wavy structures. To promote the 
neuronal attachment, extracellular matrix, which is a passive 
covalent attachment can also be used. As for an example, fixed 
astrocyte extracellular matrix offers more reduction in 
microglial activation as compared to the individual extracellular 
matrix components such as laminin or fibronectin [74-76]. By 
exploiting the reliance of bending stiffness on implanted device 
size, only the mesh electronics associated with compelling 
mechanical properties practically identical to that of neural 
tissue (Fig. 5b).  
The chronic performance of the neural devices mostly 
depends on their dimensions, stability of their material and 
functionalities, proper encapsulations, and mechanical 
properties to reduce the foreign body response. Glial scar 
formation and displacement of tissue can be diminished by 
miniaturizing the size of the device, which can be achieved by 
reducing the cross-sectional area to decrease the stiffness of the 
device. As a result, reduction of implant dimensions to below 
several microns increase the bendability of neural devices, 
which results in less displacement and glial scar [77-79]. The 
application of emerging materials such as carbon fibre (7 µm in 
diameter) for long-term recording of neural activities has 
induced minor gliosis and neuron loss [80]. However, 
developing carbon fibre arrays is a difficult task and one 
electrode site per fibre limits the carbon fibre array 
configuration. On the other hand, recently a mesh electronics 
array configuration called neuron-like electronics (NeuE) has 
been proposed with features sizes analogous to the neuron axon 
and attunes extremely low bending forces, which results in 
minimum inflammation and foster implant-neuron interaction 
[81]. Consequently, such mesh electronics are chronically 
stable for recording up to 3~8 months [5, 35, 81]. However, the 
trade-off remains as a syringe is required to inject the mesh 
electronics without having the precise control over the 
implantation [66]. Furthermore, neuron-scale devices are yet to 
showcase their length of service to confirm the applicability in 
larger animals. 
To reduce mechanical discrepancy between the brain tissue 
and the implantable device, a hot topic of research is the use of 
a soft and flexible [82-84] or stretchable [85-88] system for 
implantable neural device. Although flexible and 
stretchable/elastic implants have achieved minimum foreign 
body response when implanted chronically, thorough and 
outright correlation in performance for chronic recording 
between flexible and conventional silicon/metal devices is 
required to be investigated. On the other hand, such flexible and 
soft devices also introduce complexities in implanting the 
device inside the brain. To this end, these problems are 
managed by using encapsulation approaches  such as silk [89], 
carboxymethyl cellulose [90], syringe injection shuttles [66, 
 
Fig.  5. (a) Schematic illustration of Young’s modulus of common materials and tissue demonstrate the mechanical compatibility 
between the rigid materials (metals, Si, oxides; left), against the elastomers like PDMS (middle) (b) Comparison of bending 
stiffness among traditional and recent implantable neural devices. (c) Current trend in implantable neural device designing includes 
use of biocompatible polymers, unique serpentine structure, mesh electronics, conductive polymer, and nanostructures. 
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91], or magnetic insertion [92]. As current trends are 
progressing towards making these devices smaller and more 
flexible, more advanced and durable biocompatible materials 
are desirable. Then again, ultra-small and flexible devices are 
susceptible to material and physical failure due to their 
geometry. Thin encapsulation is another essential criterion for 
these devices. Most commonly used flexible polymers (e.g. 
Polyimide and Parylene C) for ultrathin (<1 μm) encapsulations 
have difficulties in chronic stability and reliability [93], 
expressing the need of further improvement on insulation 
materials/methods. Upon stretching/flexing, materials require 
to exhibit both conductivity as well as flexibility.  A promising 
advancement in elastic conductors has been revealed through 
nanoconfinement effect [94]. The application of such materials 
for implantable neural implants is yet to be explored.  
The impedance of the electrode increases, if its size is 
minimized to record or stimulate single or small numbers of 
neurons. There is a well-known trade-off between the electrode 
area and impedance. While averaging over a big population of 
neurons, in general, bigger regions decrease Rspread and add to 
the capacitance, Ce. In any case, the need to quantify action 
potentials of individual neurons with a high-resolution 
proportion has prompted a staggering spotlight on augmenting 
Ce while minimizing the implantable device size. Surface 
alteration of the electrode by strategies, for example, 
nanostructured coatings and including composite films made of 
carbon nanomaterials have been broadly explored [95]. 
Nanostructured coatings permit a critical increment in the 
surface area of the probe/tissue interface and are regularly 
utilized for multielectrode arrays. An indistinguishable 
methodology has been taken with carbon nanostructures 
(carbon nanotubes and graphene) [96, 97] as well as their 
composites, and results in an identical results [98]. Carbon 
nanotubes (CNT) based Magnetic Resonance Imaging (MRI) 
compatible neural probes have also been developed to combine 
functional MRI (fMRI) studies across entire brain regions 
without any electrode interferences [99]. Likewise, conductive 
polymers present another unique option to improve the 
performance of the electrode. Conductive polymers such as 
poly(3,4-ethylenedioxythiophene) (PEDOT) and Polypyrrole 
can give a mix of ionic infiltration and adequate pathways for 
electronic conduct, which yield remarkable increment in 
capacitance per unit geometric surface area than normal 
metallic electrodes and, therefore, improve both recorded signal 
strength and stimulation capacity [45]. Conductive polymers 
can be promptly functionalized through physical ensnarement 
and covalent cross-connecting with biomolecules and cells, 
which can viably dim the biotic/abiotic interface and improve 
biointegration [44, 95, 100, 101]. Additionally, to ease the 
functionality and improve the stability, advanced conductive 
polymers have been investigated in dopants for neural 
recording [78, 102] and drug delivery [103]. These novel 
polymer coatings enable more reduction in dimension for 
implantable neural devices. 
 
 
 
TABLE I 
NOVEL NEURAL PROBE TECHNOLOGIES 
Emerging 
Technology Scale and Features 
Long-term 
chronic 
reliability 
Functionalities  Reference (s) 
Neurotassels 
1024 microelectrode filaments, 
each with a cross-sectional 
footprint of 3×1.5 µm2 
 
3-6 weeks after 
implantation 
Neural activity recordings for behavioral training in mice. 
Can be integrated with optical fiber for simultaneous 
stimulation and recording. 
 
Neuropixels 
Silicon Probe, 960 channels on a 
single, 10-mm long, non-tapered 
shank with 70×20-μm cross-
section 
Up to 60 days 
Simultaneous neural activity recording from multiple brain 
regions to address the relationship of behavior to activity 
distributed across the brain 
 
     
Neurogrid 120–256 channels; electrodes are 
10 × 10 µm2 with 30-µm 
interelectrode spacing, use of 
PEDOT: PSS as interface 
material 
 
10 days  
Recording large-scale neural activities such as LFP and AP 
in the dorsal cortical surface 
 
NeuE (Mesh 
Electronics) 
~0.9 μm in total thickness flexible 
polymer probe, comparable to 
Axon 
 
Up to 3 months 
Stable single-neuron recording of individual cells and holds 
promise as a transplantation-free regenerative medicine. 
 
Multifunctional 
probe 
Silicon probe, electrical 
recording, optical stimulation, 
fluidic delivery, 128 μm in width 
40 μm in thickness each shank 
 
2 weeks 
Can be used in complex brain circuit studies where three or 
more brain regions are connected 
 
e-Dura mater 
 
Elastomeric substrate (PDMS), 
120 µm in thickness, stretchable, 
multifunctional 
 
6 weeks Rehabilitation and therapeutic application for spinal cord 
injury 
 
MRI compatible 
flexible probe 
CNT fiber based, fiber minimum 
diameter 5 µm. 
 
6-12 weeks Soft and MRI compatible neural electrodes enable stable 
chronic electrophysiological measurements and anatomical 
or functional MRI studies of the entire brain 
 
 
3D probe Silicon based, 1024 electrodes per 
0.6 mm3 
Possible but not 
evaluated 
Recording of coordinated activity of large populations of 
neurons distributed across the brain 
 
 
MRI-Magnetic Resonance Imaging; LFP-Local Field Potential; AP- Action Potential 
 
[71], 2019  
[49], 2017  
[102], 2015  
[81], 2019  
[50], 2019  
[72], 2015  
[99], 2019  
[51], 2016  
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The aforementioned strategies improve the mechanical and 
physical properties of the implanted neural devices to promote 
biocompatibility for probe/tissue biointegration. However, the 
recorded signal quality is affected due to miniaturized device 
size, number of channels, high signal-to-noise ratio, or less 
invasive approaches [104]. As a result, in addition to softness 
and biocompatibility of the device, further design methods and 
traits are also necessary. However, a detailed discussion on 
these topics is beyond the scope of this review. Table I 
summarizes and compares different properties of emerging 
electrode technologies.  
D. Stimulation and closed-loop Implantable neural devices 
For stimulation, electrical or focal brain stimulation is the 
conventional technique used in BMI. For instance, epilepsy is 
now treated by electrical stimulation of vagus nerve. However, 
electrical stimulation of undesired neurons introduces shortness 
of breath, cough, throat pain, thereby restricting the extent of 
this approach [105]. This method has also been applied for 
motor control in patients having stroke and spinal cord injury to 
excite the paralyzed muscles [106]. Such stimulation of the 
paralyzed muscles, nevertheless, wear out the  muscle strength 
due to the disorganized enlisting of unwanted motor elements 
[107], and unable to confine muscle contractions in spasticity.  
Recently, optogenetics [108, 109], where light is used to 
stimulate the genetically  modified neurons, has enlighten with 
another unique option for neuromodulation. This genetic 
modification of neurons is engineered by using light-responsive 
proteins named as opsins to realize light-based stimulations or 
inhibition. Light-sensitive proteins such as Channelrhodopsin 2 
(ChR2) initiates action potential, whereas Halorhodopsin 
(Halo) triggers neuron inhibition, and Archaerhodopsins (Arch) 
prompts action potential inhibition. Upon light stimulation 
(blue), the ChR2 depolarizes the targeted neuron by opening the 
cation channel. Then again, upon yellow light illumination, 
another protein NpHR (Halo) results in an inhibitory effect due 
to injection of chloride ions into the neuron. Optogenetics 
enables cell specificity [110] as this method can inhibit [111, 
112] and/or stimulate cells [113] and capable of treating brain 
diseases such as nerve injury [114] and neuropathic pain [115] 
to name a few. In addition, light-based neural modulations can 
be carried out effortlessly as it is free of electromagnetic 
interference. Furthermore, as compared to electrical 
stimulation, light-based stimulation can be confined to only 
genetically modified neurons, as illustrated in Fig. 6. As a 
result, optogenetics ensures immaculate manoeuvre of neural 
modulations, which has also been another key challenge. 
However, optogenetics is still in the development phase, mostly 
tested on animals, and requires genetic modifications.  
Simultaneous capability of neural recording and stimulation 
is actively pursued to ensure versatile and long-term recording 
and stimulation implantable neural systems [116, 117]. Such 
closed-loop neuromodulation system, in general, may include a 
power management system, recording electrodes, signal 
processing core, electrophysiology unit as well as stimulation 
system that can be either optogenetics or electrical as shown in 
Fig. 7. Optogenetics modulation offers less interference with 
simultaneous electrical recordings and optical stimulation than 
does electrical stimulation. However, a typical complication 
associated with electrical recordings and optogenetics is 
undesirable electrodes’ response to the light [118].  This is due 
to the fact that in case the light strikes a metal electrode, it 
introduces an artefact due to the photovoltaic or Becquerel 
effect. The amplitude of these artefacts can be significant and 
long-lasting, causing potential data loss and/or distorts recorded 
neuronal signal. Therefore, electrode recordings during 
optogenetic stimulation are complicated for neural modulation. 
Recently, several artefact-free closed-loop battery-powered 
optogenetics/opto-electrophysiology systems have been 
introduced [119-124]. Some of the strategies that can reduce 
light artefacts are using graphene electrodes [119], covering the 
electrode with opaque polyimide [120], or reducing 
photopotential [121]. Additionally, the battery-powered head-
mounted optogenetics closed-loop devices permits majority of 
the system to stay outside the body. As a result, these systems 
provide the options for modification to perceive diverse multi-
modal platforms with less restrictions on size and scale, 
powering methods, and electronic designs. Nevertheless, due to 
the relative bulkiness and size, this method limits its application 
for chronic implantation and is more susceptible to physical 
injury due to the external mass. In the next section, fully 
implantable wireless neural devices will be discussed.  
IV. FULLY IMPLANTABLE WIRELESS NEURAL DEVICE 
Traditional methods for optogenetics depend on stiff and 
battery-powered systems to transfer power to the brain from 
outside power supplies [125]. Such method harms the normal 
tissue environment due to the micro-motion introduced by these 
systems. For optogenetics, recent researches have focused on 
reducing mechanical stress and damage of tissue by minimizing 
implant size by applying SU-8 waveguides coupled with small 
 
Fig.  6. Left) Electrical stimulation will excite all the neurons in a given 
region without sparing the non-targeted neurons. Right) Optogenetic 
stimulation excite only genetically engineered neurons (using protein 
ChR2, depicted green neuron) excluding the non-targeted neurons, 
shown as grey neuron. 
 
 
Fig.  7. Schematic of a head stage closed loop neural modulation 
system.  
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laser diode and integrated silicon devices based on microscale 
inorganic light-emitting diodes (µ-LEDs) [126-129]. 
Nonetheless, their rigid mechanisms still misaligned with the 
soft tissue of the brain [130], which institutes substantial tissue 
trauma and swelling as time goes by, as described before. Other 
approaches to address this issue made use of biocompatible 
flexible polymers [131, 132], which also rely on wired or 
tethered systems  with external sources and cause excessive 
mechanical pressure and continuous annoyance in freely 
moving rodents by obstructing their normal behaviour. In recent 
years, thanks to the wireless power engineering, significant 
advancements have been achieved by integrating wireless 
methodologies to enable chronic in vivo implantable neural 
device in freely moving animals. Ultrasonic  or induction based 
power supplies for signal and/or power communication [88, 
133-136] are some of the most commonly used techniques for 
wireless interface. Integrating these wireless implantable 
devices with multichannel and/or optofluidic channel, while 
challenging, may enable simultaneous neural recording and 
stimulation or drug delivery. These elusive combinational 
wireless technologies will enable to study long-term 
progression and recognize future therapeutic interventions for 
psychiatric and neurological conditions such as schizophrenia 
or Parkinson’s disease. Although relatively new, there is a 
recent surge in developing wireless implantable neural system 
and the potential benefits of wireless devices are tremendous. 
In the following subsection, progress in wireless system for 
both conventional electrical stimulation and optogenetics will 
be discussed. 
A subset of wireless solutions for development of an 
implantable neural device will be explored, as illustrated in 
Fig. 8. These wireless technologies mainly include ultrasound, 
electromagnetic, and solar. The thought for choosing the 
suitable wireless innovation incorporates propagation 
characteristics, implant size, and power adequacy. In view of 
this, we give a correlation in Fig. 9 between the diverse wireless 
power transfer schemes. 
i. Electromagnetic Near-Field Based Wireless System: 
Proposed device in [137] consists of a spiral coil for wireless 
power, impedance matching capacitor, a chip mounted on the 
surface for control, a rectification circuit, and a µ-LED to 
realize the optogenetic stimulation (Fig. 8a). PDMS and 
Parylene C insulations were also provided to prevent shorting 
between the wireless receiving circuit and subdermal fluid. 
Near field communication (NFC~13.56 MHz), based on the 
electromagnetic induction is the underlying principle of the 
energy harvesting circuit. The coil occupies a total volume of 
9.8 × 60 × 18 µm3. For a successful operation, this wireless 
system requires transmitter with loop antennas aligned properly 
to the receiver circuit implanted in the brain to transfer power 
efficiently. Applying the NFC method for optogenetic 
stimulation and wireless power enables an in-expensive and 
comparatively simple way regarding wireless implantable 
neural systems. In addition, this methodology of wireless 
powering utilizes low-frequency near-field domain and 
generates less specific absorption rate in tested animals in 
comparison with far-field systems and provides smaller loss 
than high-frequency band. Although the size of the implanted 
device is smaller than other related designs for neural 
modulations, larger coil size (diameter of 9.8 mm) limits the 
implantation of multiple devices. 
ii.  Electromagnetic Mid-Field Based Wireless System:  
To stimulate the spinal cord, brain, and peripheral nerve, a 
completely implantable wireless system based on optogenetics 
 
Fig.  8. Numerous wireless solutions demonstrate the various scale of the implants including electromagnetic (near-field, mid-field, and far-
field), solar, and ultrasound. 
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is presented by Ada poon et al. [134]. They made use of 
evanescent signals emanating from a metallic resonant cavity, 
and mice are positioned on the top of this resonator to receive 
power wirelessly to steer a blue LED. In their previous research 
they demonstrated that due to the difference in dielectric 
properties between the tissue and free space, permits 
electromagnetic energy to be confined to the mice body. This 
method also alleviates the requirement of an additional tracking 
mechanism generally applied to assure consistent wireless 
power. The wireless power transmission was composed of a 
wireless power receiving coil (diameter 1.6 mm), rectifier, 
circuit board and the metallic RF cavity resonator (Aluminium, 
21 cm diameter, 15 cm height) resonated at midfield band of 
1.5 GHz. The entire implant including a blue µ-LED is 
demonstrated in Fig. 8b and measures about 20-50 mg and 
accommodates a volume of 10-25 mm3. For optogenetics 
excitation, the optimum efficiency of the µ-LED (light 
emitted/power input) is 19%. This level of power is more than 
enough to radiate the optical density of 1–20 mW/mm2 for 
optogenetics stimulation. Due to the stiff structure and as this 
wireless operations needs a big metallic resonator that transmits 
radio-frequency power to supervise the implant, this method 
applicable in a regulated lab scenario and not for chronic cases. 
iii. Electromagnetic Far-field Based Wireless Power System 
As compared to the stiff implant of Montgomery et al. [134], 
advancement in soft and flexible electronics empowered to 
develop an energy harvesting system, which is stretchable, 
flexible (PDMS encapsulated), and fully implantable [88], as 
shown in Fig. 8c. The implant consists of four key parts: a 
power harvester, rectifier circuit along with a voltage 
multiplier, and a very small 470 nm LED. PDMS encapsulation 
of the implant ensures not only protection from the adjacent 
tissues but also forms a physical and mechanical alliance with 
the tissue. Due to smaller size (6 × 3.8 × 0.7 mm3) and 
lightweight (16 mg), the device is available to implant 
subdermally in numerous crucial areas of peripheral and central 
nervous systems to support in vivo optogenetics. By reducing 
the thickness of the PDMS encapsulation, the implant can 
achieve lighter, slimmer, and bendable profile to facilitate the 
biointegration with tissue. A stretchable antenna having a 
miniaturized surface area of 3 × 3 mm2, resonating at 2.3 GHz 
with a 200 MHz bandwidth, is a key component of this device 
to harvest the RF energy.  Due to the significant higher 
bandwidth than the traditional patch antenna, this type of 
receiver antenna can enhance the energy harvesting efficiency. 
The transmitted RF signal is generated by another antenna from 
the base station. Identical RF signals are applied to energy 
harvesting as well as control signalling to power the LED. 
Despite the unique characteristics, the resonant frequency of the 
stretchable antenna may change due to deformity caused by the 
animal motions, and therefore, requires further optimization. 
Furthermore, the footprint of the device is too big to recognize 
a large-scale distributed optogenetics system. Recently, this 
work is further developed to a thinner and lighter device to steer 
up to four channels using a modified antenna [138]. 
iv. Solar-Powered Wireless System 
Photovoltaic energy harvesting from light [139-142] is 
another enthralling tool to wirelessly power the implantable 
devices. In [139], to replace the batteries for uninterrupted 
functioning of implants, an implantable device made of tiny, 
thin solar cells (gallium arsenide, 5 mg) along with a wireless 
logical control module based on RF signal to activate µ-LEDs, 
was introduced and depicted in Fig. 8d. The wireless control of 
this device was enabled by using a rectifier circuit that converts 
the RF signal to direct current to drive a low-power logic circuit, 
which is integrated with solar cells and LEDs. As compared to 
the identical system without photovoltaics, this combination of 
solar and RF wireless system improves the wireless power 
transfer range capability (~3 m) and simultaneously lower the 
RF power requirements substantially (almost by a factor of 10). 
As a result, this system significantly reduces electromagnetic 
exposure to animals as well as enabling free, natural behaviour 
in animals. This is a head-mounted wireless system, where the 
solar cells are placed on top of the head of a rat. 
In another work [143], a photovoltaic wireless power transfer 
system based on CMOS (complementary metal-oxide 
semiconductor) applicable for tiny (≤1-2 mm) implantable 
electronic devices is introduced. To integrate the photovoltaic 
cells, the implant contains a CMOS power receiver chip having 
surface area of 1.25 × 1.25 mm2. By using the infrared light, 
TABLE II 
COMPARISON OF THE RECENT FULLY IMPLANTABLE WIRELESS POWERING TECHNOLOGIES 
Powering 
Scheme Scale and Features Frequency Encapsulation Range SAR/Heating Reference (s) 
Near-Field  
Implant Diameter: 9.8mm 
Thickness < 1.3 mm 
Weight~ 30 mg 
 
13.56 MHz Parylene C ~0.1 m <20 mW/kg  
Mid-Field 
Implant volume: 10-25 mm3 
Weight: 20-50 mg 
1.5 GHz Light-cure 
acrylic 
~0.03 m <1 oC  
       
Far-Field Implant size: 0.7 mm × 3.8 mm × 
6 mm  
Weight: 16 mg 
 
2.3 GHz PDMS ~0.2 m ~69 mW/kg 
 
Solar Powered Implant size: 1-1.7 mm3 
Weight: 2.3 mg 
 
N/A N/A N/A N/A  
Ultrasound Implant size: 0.8 mm3 
 
1.78 MHz Parylene C ~0.03-0.05 m N/A  
       
N/A: Not Applicable 
 
[137], 2017 
[134], 2015 
[88], 2015 
[143], 2018 
[133], 2019 
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this implant successfully powered a blue LED. Then, the 
CMOS chip as well as a few off-chip parts were integrated to 
develop an implantable optogenetics device (1 mm3). However, 
light sources nature, proximity, and direction limits the solar 
cells wireless powering ability for implantable neural devices.  
v. Ultrasound based Wireless System  
Among others, Maharbiz et al. studied the ultrasound based 
wireless neural implants as evidenced through their Neural Dust 
[144] and Stim Dust [145]. In one of the most recent studies 
[133], they developed a 0.8 mm3 ultrasonically powered 
miniaturized wireless neural implant. The size of the recording 
IC is 0.25 mm2 only and for both power and data transmission 
a single piezoceramic resonator was used, as pictured in Fig. 8e. 
This small device with wireless power capability can minimize 
tissue damage, scar formation, and neuroinflammatory 
response. The device can operate at a depth of 5 cm, allowing 
neural recording from the deep brain regions and most 
peripheral nerves. The implants achieved simultaneous power 
and data delivery with an inexpensive unfocused single-element 
transducer placed externally. This allows for maximized 
working depth and optimum frequency thereby improving the 
spatiotemporal resolution in a distributed recording 
environment.  
Another work, STARDUST project envisions the 
implementation of an implant, which is going to be used 
primarily for optogenetics, and later as a recording device with 
a drug-delivery system. The first version of this optogenetic 
device (i.e. dust) to be used only for optogenetics has been 
fabricated and tested, which includes a PZT cube of 560 × 560 
× 490 μm3, a µ-LED of 280 × 180 × 100 μm3 and an active 
rectifier with the size of 300 × 300 μm2 [129]. The vision of this 
project is to develop a Dust with the same dimensions for other 
applications including recording and drug-delivery leading a 
full system in micro-scale dimension for freely moving animals 
for Parkinson’s disease treatment.  Ultrasound based wireless 
systems enables low signal attenuation in biological tissue, 
minimized geometry, and can be used safely with human. 
However, complicated circuitry and complexity in addressing 
the ultrasound frequency remain the two main bottlenecks. In 
addition, ultrasound-based wireless systems have low data rate 
(e.g. Kb/s), has a signal is greatly attenuated by the skull and 
needs an intermediate transceiver based on electromagnetic 
coupling beneath the skull. 
So far, some of the most common forms of wireless power 
system for implantable neural devices are discussed and 
summarized in Table II. Apart from these, there are emerging 
technologies which combines multiple stimulation  options and 
optofluidic channel [146, 147], uses innovative approach to 
achieve an ultra-miniaturized implant [148], introduces scalable 
and distributed wireless neural platform [149, 150], wireless 
optoelectronic photometer for dynamic mapping of the brain 
[151], simultaneous multichannel optogenetics stimulation and 
multichannel electrical recording system [152].  
Fig. 9 shows the comparison among different power transfer 
schemes with respect to the power transfer range to achieve the 
power requirement for the neural implants. In terms of device 
miniaturization and signal propagation, ultrasound allows 
better wireless solution than the solar and electromagnetic 
based technologies. To add more, the ultrasound energy has low 
propagation loss in biological tissues. In accordance with to 
FDA (Food and Drug Administration), the ultrasound exposure 
to the human tissue is limited to 720 mW/cm2, whilst RF is 10 
mW/cm2. Manufacturing complexity is the main obstacle of 
ultrasound technology. On the other hand, with increasing 
frequency, the antenna size can be miniaturized thus application 
of electromagnetic approaches more appealing for device 
miniaturization. As it is expected that the next-generation 
implants will require less power, lower size and form factor, the 
resonant coupling based on midfield and far-field based 
wireless power transfer would be beneficial. In addition to 
power transfer, simultaneous data transmission is another 
crucial parameter to remotely control and monitor the activities. 
Among all power transfer systems, only the ultrasound and 
near-ﬁeld methods have the capability to enable simultaneous 
power and data transfer. As a result, the near-ﬁeld inductive-
coupling scheme still can meet the power requirements by the 
most commonly used implantable devices.  In conclusion, 
implantable neural device design must consider specific types 
of power transfer schemes depending on the application for 
superior performance. 
In one of the most recent studies, a fully implantable wireless 
closed loop optogenetics system has been introduces that can 
monitor and control bladder function through a smart device 
 
Fig.  9. Comparison among different wireless power transfer scheme 
in terms of stimulation intensity and power transfer distance. 
 
 
Fig.  10. Schematic of a futuristic fully wireless implantable neural 
system that can be interfaced through a smart device for versatile 
neural modulation control. 
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[153]. The schematic of this closed loop system is given in 
Fig. 10. The authors use a soft elastomeric material (PDMS), 
which shows negligible inflammatory response after 7 days of 
implantation. The implant/smart device user interface was 
developed though a software using XCode to log the recording 
data and to provide systematic stimulations. Such system can 
be easily adapted to address several application scenarios 
beyond the bladder control. Furthermore, the sensing module 
could be modified to associate different biophysical (e.g. 
temperature, pressure) and/or biochemical (e.g. metabolites, 
proteins) sensors, as well as can be integrated with numerous 
actuators (e.g. pharmacological) to allow the appropriate 
modulation, all utilizing control given by the wireless module 
through developing a proper user interface. These wireless 
closed loop technologies may act as a platform to realize the 
futuristic vision by integrating the wireless optogenetics system 
into smart healthcare using mobile and electronic technology 
for better diagnosis of the brain diseases, improved treatment, 
and enhanced quality of lives.    
V. CONCLUSION 
Research on implantable neural device/tissue interface is one 
of the most fundamental components for neural 
engineering. The discussion portrayed here represents state-of-
the-art strategies for implantable neural probe that are now 
available. While certainly enchanting, such device strategies 
introduce additional demands on device durability and material 
stability due to mechanical mismatch and neuroinflammatory 
response. One of the most significant challenges are making 
these devices scale down to the dimension of a typical neuron 
and interfacing them to particular types of neuron. A 
combinatorial approach will require to realize an ideal neural 
device, which incorporates advanced materials and biomimetics 
as well as fabrication to seamlessly integrate with the nervous 
system for proper biointegration. On the other hand, 
communication and powering these devices emerge another 
challenge while considering the side effects that can occur to 
the brain. As a result, newly developed wireless technologies 
allow several benefits over their head-mounted or tethered 
predecessors. Realizing the development of wireless implants 
at the nano/microscale could be a significant step forward to 
future neurotechnologies for connecting engineering to 
medicine that addresses important challenges for treating 
neurological diseases. 
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